Author
Listed:
- Sara Campinoti
(Epithelial Stem Cell Biology & Regenerative Medicine laboratory, The Francis Crick Institute
UCL Great Ormond Street Institute of Child Health)
- Asllan Gjinovci
(Epithelial Stem Cell Biology & Regenerative Medicine laboratory, The Francis Crick Institute
Institute of Immunity & Transplantation, Division of Infection & Immunity, UCL, Royal Free Hospital)
- Roberta Ragazzini
(Epithelial Stem Cell Biology & Regenerative Medicine laboratory, The Francis Crick Institute
Institute of Immunity & Transplantation, Division of Infection & Immunity, UCL, Royal Free Hospital)
- Luca Zanieri
(Epithelial Stem Cell Biology & Regenerative Medicine laboratory, The Francis Crick Institute
Institute of Immunity & Transplantation, Division of Infection & Immunity, UCL, Royal Free Hospital)
- Linda Ariza-McNaughton
(Haematopoietic Stem Cell laboratory, The Francis Crick Institute)
- Marco Catucci
(Epithelial Stem Cell Biology & Regenerative Medicine laboratory, The Francis Crick Institute
UCL Great Ormond Street Institute of Child Health
Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute)
- Stefan Boeing
(Bioinformatics Laboratory, The Francis Crick Institute)
- Jong-Eun Park
(Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton
Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST))
- John C. Hutchinson
(UCL Great Ormond Street Institute of Child Health
Great Ormond Street Hospital for Children NHS Foundation Trust)
- Miguel Muñoz-Ruiz
(Immunosurveillance laboratory, The Francis Crick Institute)
- Pierluigi G. Manti
(IEO, European Institute of Oncology, IRCCS
University of Milan)
- Gianluca Vozza
(IEO, European Institute of Oncology, IRCCS
University of Milan)
- Carlo E. Villa
(IEO, European Institute of Oncology, IRCCS)
- Demetra-Ellie Phylactopoulos
(Epithelial Stem Cell Biology & Regenerative Medicine laboratory, The Francis Crick Institute
UCL Great Ormond Street Institute of Child Health)
- Constance Maurer
(Epithelial Stem Cell Biology & Regenerative Medicine laboratory, The Francis Crick Institute
UCL Great Ormond Street Institute of Child Health)
- Giuseppe Testa
(IEO, European Institute of Oncology, IRCCS
University of Milan)
- Hans J. Stauss
(Institute of Immunity & Transplantation, Division of Infection & Immunity, UCL, Royal Free Hospital)
- Sarah A. Teichmann
(Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton)
- Neil J. Sebire
(UCL Great Ormond Street Institute of Child Health
Great Ormond Street Hospital for Children NHS Foundation Trust)
- Adrian C. Hayday
(Immunosurveillance laboratory, The Francis Crick Institute
School of Immunology & Microbial Sciences, King’s College London)
- Dominique Bonnet
(Haematopoietic Stem Cell laboratory, The Francis Crick Institute)
- Paola Bonfanti
(Epithelial Stem Cell Biology & Regenerative Medicine laboratory, The Francis Crick Institute
UCL Great Ormond Street Institute of Child Health
Institute of Immunity & Transplantation, Division of Infection & Immunity, UCL, Royal Free Hospital)
Abstract
The thymus is a primary lymphoid organ, essential for T cell maturation and selection. There has been long-standing interest in processes underpinning thymus generation and the potential to manipulate it clinically, because alterations of thymus development or function can result in severe immunodeficiency and autoimmunity. Here, we identify epithelial-mesenchymal hybrid cells, capable of long-term expansion in vitro, and able to reconstitute an anatomic phenocopy of the native thymus, when combined with thymic interstitial cells and a natural decellularised extracellular matrix (ECM) obtained by whole thymus perfusion. This anatomical human thymus reconstruction is functional, as judged by its capacity to support mature T cell development in vivo after transplantation into humanised immunodeficient mice. These findings establish a basis for dissecting the cellular and molecular crosstalk between stroma, ECM and thymocytes, and offer practical prospects for treating congenital and acquired immunological diseases.
Suggested Citation
Sara Campinoti & Asllan Gjinovci & Roberta Ragazzini & Luca Zanieri & Linda Ariza-McNaughton & Marco Catucci & Stefan Boeing & Jong-Eun Park & John C. Hutchinson & Miguel Muñoz-Ruiz & Pierluigi G. Man, 2020.
"Reconstitution of a functional human thymus by postnatal stromal progenitor cells and natural whole-organ scaffolds,"
Nature Communications, Nature, vol. 11(1), pages 1-16, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-20082-7
DOI: 10.1038/s41467-020-20082-7
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-20082-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.